|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-8-4
|
|
pubmed:abstractText |
Highly active antiretroviral therapy (HAART) is often withheld from injection drug users (IDUs) infected with the human immunodeficiency virus (HIV) based on the belief that their unstable lifestyles may predetermine a markedly inferior outcome with HAART. However, long-term evaluations of HIV treatment outcomes among IDUs in comparison with other risk groups are not available.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1538-3598
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
6
|
|
pubmed:volume |
300
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
550-4
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18677027-Adult,
pubmed-meshheading:18677027-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:18677027-Female,
pubmed-meshheading:18677027-HIV Infections,
pubmed-meshheading:18677027-Humans,
pubmed-meshheading:18677027-Kaplan-Meier Estimate,
pubmed-meshheading:18677027-Male,
pubmed-meshheading:18677027-Middle Aged,
pubmed-meshheading:18677027-Prospective Studies,
pubmed-meshheading:18677027-Statistics, Nonparametric,
pubmed-meshheading:18677027-Substance Abuse, Intravenous,
pubmed-meshheading:18677027-Survival Rate
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Highly active antiretroviral therapy and survival in HIV-infected injection drug users.
|
|
pubmed:affiliation |
British Columbia Centre for Excellence in HIV/AIDS, St Paul's Hospital, Vancouver, BC, Canada.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
